BIO 2012– a carnival of contradiction
This article was originally published in Scrip
Executive Summary
BIO 2012 is a carnival of the contradictory forces in the business of pharmaceuticals. Business is vigorous, yet the model is crumbling underneath it. Governments covet this industry, but loathe paying it.